Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community

Development of a quantitative COVID-19 multiplex assay and its use for serological surveillance in a low SARS-CoV-2 incidence community

Show other versions (1)

A serological COVID-19 Multiplex Assay was developed and validated using serum samples from convalescent patients and those collected prior to the 2020 pandemic. After initial testing of multiple potential antigens, the SARS-CoV-2 nucleocapsid protein (NP) and receptor-binding domain (RBD) of the sp...

Full description

Bibliographic Details
Main Authors: Cassandra Guarino, Elisabeth Larson, Susanna Babasyan, Alicia Rollins, Lok R. Joshi, Melissa Laverack, Lara Parrilla, Elizabeth Plocharczyk, Diego G. Diel, Bettina Wagner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782306/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782306/?tool=EBI

Similar Items